Plain-English translation of NCT07355270 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type-2 Diabetes Mellitus research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new medical device called a radiofrequency vapor ablation system that uses controlled energy to gently treat the inner lining of your small intestine. Researchers believe this procedure may help people with type 2 diabetes control their blood sugar levels more effectively. The trial will evaluate whether the treatment is safe, well-tolerated by patients, and actually improves blood sugar control over six months.
Many people with type 2 diabetes struggle to keep their blood sugar in a healthy range even while taking medications. Researchers are exploring whether this new procedure could offer an additional way to help improve blood sugar control and potentially reduce the need for or dosage of diabetes medications.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will participate in the study for six months. You'll have an initial screening phase, a run-in period where your medications may be adjusted for safety, pre-procedure tests, and then the radiofrequency ablation procedure itself. After the procedure, you'll have multiple follow-up visits over 168 days (about 5.5 months) where researchers will monitor your blood sugar, check for any side effects, and assess how well the treatment is working. Throughout the study, you'll wear a continuous glucose monitor to track your blood sugar levels in real time.
AI-generated summary from trial data · Sep 5, 2026 · Not medical advice
United States